Protein bio-corona: critical issue in immune nanotoxicology by unknown
1 3
Arch Toxicol (2017) 91:1031–1048
DOI 10.1007/s00204-016-1797-5
REVIEW ARTICLE
Protein bio‑corona: critical issue in immune nanotoxicology
Monica Neagu1,2 · Zoi Piperigkou3,4 · Konstantina Karamanou3,5 · Ayse Basak Engin6 · 
Anca Oana Docea7 · Carolina Constantin1 · Carolina Negrei8 · Dragana Nikitovic9 · 
Aristidis Tsatsakis10 
Received: 26 June 2016 / Accepted: 6 July 2016 / Published online: 20 July 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
to innovative functional nanotherapies. Therefore, bio-med-
ical nanotechnologies should focus on the interactions of 
nanoparticles with the immune system for both safety and 
efficacy reasons.
Keywords Bio-corona · Nanoparticle · Immunological 
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Introduction
The evolvement of the immune system during human’s 
phylogeny and ontogeny was accomplished through expo-
sure to different chemical, physical and biological agents. 
All the immune mechanisms have been adapting to human 
environments through the course of history (Danilova 
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2013). Thus, there is a constant pressure from pathogens on 
the human immune system, an illuminating example being 
host–pathogen coevolution of myeloid Fc-alpha receptor 
1 (FcaR1), mediating phagocytosis of opsonized patho-
gens and the selection of bacterial decoy staphylococcal 
superantigen-like 7 (SSL7) of Staphylococcus aureus that 
evolved to inhibit phagocytosis (Danilova 2008).
When aggressors reach the organism, the first defense 
layer is the physical barrier that is constituted by skin and 
mucosae. These layers can make use of constitutive defense 
weapons like cutaneous/mucosal secretion, reflexes like 
nociceptive reflexes or defensive vomiting to rapidly get rid 
of any harmful aggressors. When this barrier is breached, 
pathogens or injuries that threaten the body homeostasis are 
subjected to the action of the immune system. Two differ-
ent branches of the immune system work together to restore 
homeostasis: the innate and adaptive immune systems. 
These sentinels monitor vertebrate tissues and use differ-
ent tactics to recognize and overcome threats. These two 
branches are inherently different as regarding the sensors 
and mechanisms employed in order to provide either imme-
diate protection with broad specificity (innate immunity) or 
delayed and prolonged protection with exquisite specific-
ity (adaptive immunity). Furthermore, the two branches 
must effectively coordinate a response and physiologically 
down-regulate its intensity in order to prevent excessive or 
inappropriately targeted inflammation (Janeway 1992).
During our evolution, as humans we were exposed to 
food and environmental particles, a myriad of them being 
in the nanoparticle ranges. Airborne nanoparticles have 
cohabitated with humans throughout the evolutionary pro-
cess, but the exposure has significantly increased in the last 
100 years owing to industrial revolution (Oberdörster et al. 
2005).
Nanomaterials are small particles with corresponding 
large surface area which confers to these corpuscles prop-
erties desirable for utilization in nanomedicine. The fact 
that nanomaterials have the same size range as biomole-
cules and cellular structures has an important duality. Thus, 
nanoparticles (NPs) can reach intra-cellular structures that 
were previously accessible only to biological aggressors. 
On the other hand, NPs reaching subcellular structures can 
be therapeutics in the rapidly evolving nanomedicine field, 
where applications rely on nanoscale interactions. This 
concept, however, is not so simple as in biological milieu, 
NPs interact with molecules that will completely alter their 
initial chemical structure (Fadeel et al. 2015).
In a physiological environment, the NP–protein corona 
complex formation involves absorption of protein mol-
ecules at the interfacial region between NPs and their sur-
roundings. Understanding the corona formation process is 
crucial in predicting NP behavior in biological systems, 
including applications for nanotoxicology and development 
of drug delivery platforms at the nanolevel (Shaw et al. 
2012; Sisco et al. 2014). Importantly, there is a dynamic 
interaction between NPs and biomolecular species and 
other chemical and organic matter which ultimately results 
in biological corona formation.
The resulting conformational structure of the bio-
corona, which is critically dependent on intrinsic NP 
properties, may induce alterations in extracellular matrix 
(ECM) nature. Noteworthy, ECM constituents interact 
with cell surface receptors, growth factors and cytokines, 
leading to numerous signaling cascades which are closely 
related to cell behavior (Afratis et al. 2012; Bouris et al. 
2015; Gialeli et al. 2011). Glycosaminoglycans (GAGs) 
are widely known for their roles in ECM remodeling and 
disease progression. As the most investigated ECM poly-
saccharides, they are indicated as effective pharmaceutical 
targets. Heparin, heparan sulfate and their mimetics, due 
to their anti-metastatic profile, are the protagonists in the 
GAG-based anticancer therapy (Karamanos and Tzanaka-
kis 2012; Mizumoto and Sugahara 2013; Theocharis et al. 
2015). Heparin has the highest negative charge among 
GAGs. This feature renders heparin responsible for its 
interactions with a variety of growth factors and cytokines, 
such as fibroblast growth factor (FGF), epidermal growth 
factor (EGF), insulin growth factor (IGF) and tissue necro-
sis factor alpha (TNF-α), allowing them to influence cancer 
cells’ functions, such as invasion and migration and crucial 
for the initiation and progression of metastasis, epithelial-
to-mesenchymal transition (EMT) (Afratis et al. 2012). 
Taking advantage of the expanded use of NPs and heparins 
in effective drug delivery, it has been recently reported that 
two nanoheparin analogues, the nano-Styela, isolated from 
sea squirt Styela plicata, and the nanomammalian, isolated 
from the porcine intestine, proved to be important inhibi-
tory agents of breast cancer, as they inhibited cell prolif-
eration, invasion, proteasome activity and also achieved 
to regulate apoptosis and the expression of major matrix 
macromolecules (Piperigkou et al. 2016a). Based on this 
knowledge, it is deemed of great importance to develop 
applications in a frame of bio-corona–NPs complex and 
GAGs, especially the promising heparins and their mimics.
Although the bio-corona is a highly dynamic structure 
and its composition changes over time, human serum albu-
min (HSA), immunoglobulin (IgG) and fibrinogen were 
found to be the major hard corona proteins binding firmly 
on to the NP surfaces and showing distinctive stability 
(Mahmoudi et al. 2011a, b; Monopoli et al. 2012). A recent 
study revealed that rapid human plasma corona formation 
on silica and polystyrene NPs of various size and surface 
functionalization significantly affected NP uptake (Tenzer 
et al. 2013). Protein interactions with a nanoscaled surface 
can disrupt its native conformation, compromising thus the 
protein function (Li et al. 2013). Therefore, interpreting 
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the interaction of nanomaterials with biological systems 
by taking into account the physicochemical properties of 
NPs will lead to a better understanding of bio-corona for-
mation. Indeed, the major parameters of NPs that influence 
bio-corona composition include: material, size, shape, cur-
vature, surface charge, solubility, surface functionalization 
and the route of administration to the body. Importantly, 
these properties also affect NPs distribution and their thera-
peutic effects (Lundqvist et al. 2011; Monopoli et al. 2012; 
Salvati et al. 2013).
First of all, NP size is critical factor in determining the 
affinity of protein binding. To note, the surface curvature 
has an important role in protein absorption and corona 
composition (Lundqvist et al. 2008). Computational and 
experimental studies revealed that absorbed proteins at 
the curved surface of NPs undergo less conformational 
changes than proteins adsorbed at flat surfaces of the 
same material (Mahmoudi et al. 2011a; Rahman et al. 
2013). Moreover, it has been demonstrated that NPs of the 
same surface charge but of different size absorb proteins 
with different affinities (Deng et al. 2009). For instance, 
gold NPs of larger size were coated with a thicker layer 
of absorbed proteins as compared to gold NPs of smaller 
size (Dobrovolskaia et al. 2009). NPs surface charge and 
non-electrostatic residue-specific interactions are another 
important factor that affects protein corona composition. 
A recent study revealed that the increased surface charge 
of NP resulted in higher protein absorption to bio-corona. 
Specifically, positively charged NPs absorb proteins with 
isoelectric point lower that 5.5, whereas negatively charged 
NPs absorb proteins with an isoelectric point higher than 
5.5 (Aggarwal et al. 2009). Moreover, bio-corona proteins 
are threatened by denaturation according to NPs surface 
charge. For instance, positively or negatively charged 
gold NPs denature proteins. On the other hand, neutral NP 
surface constituents do not affect proteins structure (Lun-
dqvist et al. 2008).
Another important parameter for NPs–bio-corona inter-
actions is the hydrophilicity/hydrophobicity that is corre-
lated with the surface charge. In general, hydrophilic NPs 
present decreased plasma protein absorption than hydro-
phobic NPs with the same affinity (Cedervall et al. 2007a). 
This results in more available protein-binding sites on the 
surfaces of hydrophobic copolymers (Lindman et al. 2007; 
Saha et al. 2014). Moreover, a recent study demonstrated 
that plasma proteins exhibit enhanced affinity to hydropho-
bic NP domains. For example, cholesterol-free liposomes 
bind more proteins than cholesterol-rich liposomes (Dos 
Santos et al. 2007; Karmali and Simberg 2011).
Up to date, there are limited bibliographic data as regards 
the role of surface functionalization in protein absorption. 
It was shown that non-functionalized NPs cannot agglom-
erate grapheme, whereas, conversely, PEGylated NPs have 
increased affinity to immune-competent proteins as com-
pared to albumins (Aggarwal et al. 2009; Pozzi et al. 2014). 
Recent study that assesses several parameters in the protein 
absorption by gold NPs revealed that the total amount of 
protein binding was governed only by the molecular weight 
of PEG coating (Dobrovolskaia et al. 2014). In summary, 
understanding the influence of NPs to bio-corona forma-
tions will be a key for safe and efficient design and applica-
tion of NPs.
Exploiting the dynamic process of protein bio-corona 
development in combination with the new engineered hori-
zons of drugs linked to nanoparticles could provide innova-
tive functional nanomedicine approaches. Engineered NPs 
paired with a bio-corona have already been utilized both 
in vitro and in rodent in vivo models for pharmacokinetic 
purposes (Eliasof et al. 2013). Before proceeding to human 
clinical trials, many physiological factors must be seriously 
considered, such as the nature of corona proteins and, as 
regards the species used in vivo, their basal metabolic rate, 
their circulation blood levels and importantly their size. 
Indeed, the importance of the body surface area has already 
been established, showing the allometric relation of the 
conjugation and the cellular uptake (Eliasof et al. 2013). 
Based on this theory, concerns are raised regarding the dis-
tribution and the evolution of NPs–bio-corona complexes 
inside the human body, because of human body size and 
the circulation time needed (Sahneh et al. 2015).
Nanoparticles characteristics influencing 
bio‑corona composition
Nanoparticles interactions with biomolecules are influ-
enced by a number of various factors, with additional 
effects regarding the structure of the ensuing bio-corona. 
In that context, given the place for protein adsorption (i.e., 
the NP–direct environment interface), it stands to reason 
that protein corona formation should depend on physical 
and chemical characteristics of both NPs and their bio-
logical surroundings (Piperigkou et al. 2016b). Protein 
adsorption on NP surface is therefore influenced by such 
determinants as NP components and configuration (Roach 
et al. 2005; Maiorano et al. 2010), their hydrophobic/
hydrophilic characteristics (Walczyk et al. 2010) and sedi-
mentation (particularly in systems of in vitro exposure) 
(Dutta et al. 2007), whereas as regards the surrounding NP 
environment, one may mention among others factors such 
as the temperature, pH and incidence of certain functional 
groups.
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NP influencing factors
NP components and configuration
Nanoparticle components and configuration and the result-
ing surface chemistry have a key influence as to which par-
ticular proteins may bind to NPs as well as on their specific 
affinities. According to a study conducted in that respect, 
focused on the specificity of the binding of proteins in 
human plasma to metal oxide NPs available on the mar-
ket (e.g., zinc oxide, silicon dioxide and titanium dioxide) 
under conditions of similar surface charge, titanium and 
silicon dioxide NPs adsorb related proteins (e.g., alpha-2-
acid glycoprotein, apolipoprotein D, clusterin) which differ 
considerably from those adsorbed by zinc oxide NPs (hap-
toglobin-alpha, Ig heavy chain alpha, transferrin) (Deng 
et al. 2009).
NP size
Studies have been conducted which show the key role of 
NP size to determine the type of proteins adsorbed to NP 
surfaces, thereby influencing bio-corona composition (Lun-
dqvist et al. 2008; Vertegel et al. 2004). Indicative is the 
study by Lundqvist et al. (2008) conducted on polystyrene 
NPs of sizes varying between 50 and 100 nm, demonstrat-
ing discrete protein corona formation when these NPs were 
exposed to human plasma. Furthermore, an investigation 
of the influence of silica NP size on lysozyme adsorption 
revealed the determining role of NP size in establishing 
adsorbed lysozyme structure and function (Vertegel et al. 
2004). Moreover, NP size is an important determinant of 
NP surface curvature, the latter strongly influencing the 
composition and conformation of adsorbed to corona pro-
teins (Lynch and Dawson 2008). The characteristic, as 
compared to bulk materials, NP surface high curvature 
determines protein-binding affinities distinct from those of 
bulk materials similar in composition (Hill et al. 2009). In 
actual terms, NP highly curved surfaces are characterized 
by lower inter-protein interactions, which results in marked 
differences in protein corona composition. Inter-protein 
interactions represent the interplay mediated by electro-
static forces and/or molecular docking between proteins, 
phenomenon that can take place in the protein bio-corona 
(De Las and Fontanillo 2010). Characteristically, in the 
same material, the number and frequency of conforma-
tional changes are lower in proteins adsorbed at NP highly 
curved surface in comparison with those occurring in pro-
teins adsorbed at flat surface areas (Lynch et al. 2011; Rah-
man et al. 2013). For instance, in studies of protein corona 
formation of silica NPs of differing size upon exposure to 
blood plasma (Tenzer et al. 2013), it has been shown that 
NP size significantly influenced protein binding and corona 
composition of proteins identified, even in cases of particle 
size variations as low as 10 nm. In the same manner, larger 
silica NPs were found to adsorb such proteins as prothrom-
bin or gelsolin (regulating actin), whereas lipoprotein clus-
terin was shown to bind to small silica NPs. Further studies 
along the same lines had, however, disclosed no correlation 
between adsorption of proteins such as actin or immuno-
globulin (IgG) and NP size (Tenzer et al. 2013).
An additional study investigating interactions between 
human plasma and incubated colloidal gold 30- and 50-nm-
sized NPs had shown adsorption of a greater range of pro-
teins on the smaller gold NPs as compared to the larger 
ones. This may be attributed to the multi layered interac-
tions, as when a cationic protein binds anionic gold surface 
at one site, it results in the positioning of another anionic 
protein at an alternative site (Dobrovolskaia et al. 2009). 
More recently, the effect of NP size on the binding and Hill 
constants was investigated (Lacerda et al. 2009), focus-
ing on gold NPs (5–100 nm) incubated in ordinary human 
blood proteins (albumin, γ-globulin, fibrinogen, insulin and 
histone). Consequently, the study found a significant cor-
relation between the size of studied NPs and both the bind-
ing (K) and the Hill constants, more specifically the former 
constant increasing and the latter decreasing with NP size. 
At the same time, the thickness of the protein corona is also 
directly dependent on NP size, as is conformational change.
Hemocompatibility is another important issue in the 
protein bio-corona field. Coronas developed on silica and 
polystyrene NPs were constituted, in less than a half min-
ute, of more than 300 different proteins. The complexity 
and rapidity of corona formation can induce hemolysis, 
thrombocyte activation, Nuptake and endothelial cell death 
(Tenzer et al. 2013). On single-walled carbon nanotubes, 
human serum proteins comprising the corona bind com-
petitively and exhibit altered cellular interaction pathways 
which results in a reduced cytotoxicity of coated NPs (Ge 
et al. 2011). More recent studies have shown that the com-
position of the protein corona did not correlate with NP 
hematocompatibility; hence, when assessing hematotoxic-
ity, new updated tests should be put in use (Dobrovolskaia 
et al. 2014).
NP shape
Nanoparticle shape as well plays an important role, strongly 
influencing the general biological responses to the NP and 
more specifically the manner of protein adsorption onto NP 
surface. Studies carried out in that respect have revealed 
an impressive effect of gold NP shape on their interac-
tions with the various layers of the cell and, in particular, 
the more pronounced associations of cells with spherical-
shaped than with rod-shaped gold NPs (Cox et al. 1999). 
The same selective effect of NP shape on protein binding 
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has been shown in a study on titanium dioxide NPs, i.e., 
spherical NPs were unique in displaying apolipoprotein D 
and clusterin, whereas no such proteins were identified on 
rod- or tube-shaped NPs (Deng et al. 2009).
NP modifying by functional groups/coating
For undesirable protein absorption, mechanisms can be 
put in place to either prevent or control composition of the 
protein corona. One such mechanism is to provide the NP 
surface with certain functions, through incorporation of 
various chemical groups, which “hide” it from the “sight” 
of immune cells. A second similar mechanism would be 
the coating of the NP surface with polymers as polyethyl-
ene glycol-PEG, in practice known as PEGylation, meant 
to prevent NP recognition by the reticuloendothelial system 
(RES) and reduce protein binding. By inhibiting the genera-
tion of the biomolecular corona, a remarkably rapid trans-
port of NPs across the endothelium can be achieved. One 
added advantage of this approach is the possibility to control 
PEG density on NP surface, allowing for longer circulation 
in the blood stream. Alternatively to PEG, silicon may also 
be used as a coating agent, exhibiting the same beneficial 
effect on protein adsorption (Gref et al. 2000; Perry et al. 
2012; Engin et al. 2015). In practice, studies have been con-
ducted in order to examine the abilities of various coating 
agents to provide control over NP–protein interaction. For 
instance, the action of polystyrene NPs provided with vari-
ous functional groups on cultures of endothelium cells was 
studied (Ehrenberg et al. 2009). These authors concluded 
that the ability of NP surfaces to adsorb protein is a marker 
of their propensity to interact with cells as well as that the 
identity of bound proteins does not influence cell–NP asso-
ciation. The utilization of various coating agents (PEG, 
Pluronic F127, poloxamer, dextran, poly(oxyethylene), 
polysorbate and poloxamine) enhanced control over various 
aspects of NP–protein interactions including protein binding 
and NP bio-distribution (Aggarwal et al. 2009).
For instance, one study targeted the action of polysty-
rene NPs provided with a surface functionalized with vari-
ous functional groups on endothelium cell cultures show-
ing the possibility of control on NP–cell interaction as well 
as the lack of influence of bound protein identity on the 
cell–NP association (Ehrenberg et al. 2009). Studies in that 
respect also included polystyrene nanospheres coated with 
poloxamine 908. This approach revealed a reduced adsorp-
tion of fibronectin to coated NPs in this manner in com-
parison with coat-free similar nanospheres (Moghimi et al. 
1993). Likewise, pluronic F127 coating of both amorphous 
silica particles and single-walled carbon nanotubes was 
demonstrated to increase NP dispersion and significantly 
diminish serum protein adsorption (Dutta et al. 2007).
NP surface charge
The NP surface charge is an important determining fac-
tor in the composition of the protein corona as well as in 
the evolution of the respective biological system. Thus, 
opsonins readily recognize positively charged NPs, lead-
ing to their removal by the RES and formation of deposits 
at the liver and spleen level (Mahmoudi et al. 2011a, b). 
To prevent such detrimental occurrences, the coating of 
the NP surface with negatively charged groups (with the 
effect of a 30–50 mV range negative zeta physiological 
potential) is a feasible option. On exposure of coated NPs 
to the biological environment, proteins adsorbed on the 
respective surface induce marked decrease in zeta poten-
tial to negative, 5–10 mV (Ehrenberg et al. 2009), which 
shows the direct relation between the protein corona 
nature and the colloidal stability of such complexes. In 
a separate study, conducted on gold NPs provided with 
negative, neutral and positive ligands, it has been dem-
onstrated that charged ligands (irrespective of charge) 
induce protein distortion, whereas neutral ligands allow 
preservation of protein structure (Lynch and Dawson 
2008). Moreover, upon investigating the surface charge 
density impact of negatively charged polymeric NPs, it 
was found that an increase in NP surface charge density 
leads to increased absorption of plasma protein (Gessner 
et al. 2002). Furthermore, it has been demonstrated in the 
case of polystyrene NPs that proteins <5.5 in isoelectric 
points are preferably adsorbed on the positively charged 
surfaces, in contrast to proteins >5.5 in isoelectric points 
which have an intrinsic affinity to negatively charged NPs 
charged.
NP hydrophilicity/hydrophobicity
In addition to protein adsorption capacities being higher to 
NPs with a hydrophobic surface as compared to NPs bear-
ing hydrophilic surfaces, the former NPs have a higher 
capacity to distort proteins adsorbed at their surface and 
induce loss of their original structure (Roach et al. 2005). 
Similarly, in a separate study, it has been shown that in 
the formation of the protein corona, hydrophobic NPs 
have an affinity for apolipoprotein binding, in contrast to 
hydrophilic NPs, which display a typical adsorption pref-
erence for fibrinogen, IgG and albumin (Cedervall et al. 
2007a; Gessner et al. 2000). Moreover, the direct relation 
is reinforced by study findings showing increase in protein 
stoichiometry with elevation of hydrophobicity (Cedervall 
et al. 2007b), as well as shorter albumin residence time on 
hydrophobic than hydrophilic particles with a concomitant 
higher coverage of hydrophobic particle surface at the point 
of equilibrium.
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Biological environment factors
The components and organization of the biological setting 
where the NP–protein interaction is perpetrated constitute 
an additional group of key factors which influence the com-
position of the protein corona (Nel et al. 2009; Roach et al. 
2005). A study was therefore undertaken and conducted in 
various biological environments in order to demonstrate 
this impact. The study was performed by incubating gold 
NPs with citrate caps of varying sizes, in commonly used 
cellular media including Roswell Park Memorial Institute 
medium (RPMI) and Dulbecco modified Eagle’s medium 
(DMEM) to which fetal bovine serum—FBS—was added, 
all only differing in amino acid, glucose and salt content 
(Maiorano et al. 2010). In continuation, the DMEM- and 
RPMI-mediated corona formation on the gold NPs was 
analyzed by a number of techniques, leading to a range of 
revealing conclusions such as: a significant dependence on 
time in the case of DMEM-mediated formation of protein 
corona, on one hand, and a reduction, accompanied by spe-
cific dynamics, of RPMI protein corona.
Human epithelial cervical cancer as well as a human 
leukemic monocyte lymphoma cell line (U937) was treated 
with 15-nm gold NPs in both DMEM and RPMI media, 
and in continuation, various viability assays were per-
formed. This approach revealed substantial differences in 
cellular uptake, dynamics and NP–protein complexes bio-
distribution. Thus, in RPMI-cultured cells, NP–protein 
complexes were internalized to a markedly higher extent 
as compared to DMEM-cultured cells, leading to enhanced 
cytotoxic effects. Furthermore, RPMI-induced protein 
corona was inferior in abundance and stability compared to 
the protein corona formed in the DMEM culture (Maiorano 
et al. 2010). Thus, these authors conclude that in dynamic 
extracellular environments, the original biological identity 
may become altered, and with it cellular uptake. Last but 
not least, mass spectroscopy and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) used to 
characterize NP–protein complexes showed that composi-
tion of the protein corona is not related to serum protein 
amounts (Maiorano et al. 2010). All the above differences 
in NP–protein complexes show that cellular response is 
affected by both NP and NP environmental-specific fea-
tures, which points to the importance of in-depth assess-
ment of the two elements to more accurately determine 
their putative interactions.
Other factors
In addition to specificities of the biological milieu and the 
NP in question, one must not rule out the potential action 
of several other less obvious factors such as plasma con-
centration, gradient plasma, temperature and composition 
of the cell membrane, acting at the level of the bio-nano-
particle interface, whose capacity to determine the protein 
corona composition and the ensuing cellular response must 
not be overlooked. All the above emphasize the need for 
comprehensive research to elucidate all influencing factors 
and thus allow for better formulation of nanomedicines, 
prevention of undesirable events and thus development of 
efficient high-quality nanotherapeutics.
New immunological identity of nanoparticles
The bio-corona entity as vehicle for immunological iden-
tity has been recently introduced. NPs interacting with 
biological systems have a surface corona of biomolecules 
that may dictate their biological behavior. Hence, 2 years 
ago the concept of “synthetic identity” characterizing the 
material’s intrinsic properties which can trigger the “bio-
logical identity” sustained mainly by the bio-corona com-
ponents was launched. The complex characteristics of the 
bio-corona will determine the interactions of NPs with cells 
and tissues. Therefore, the duality stated in introduction, 
nanotoxicology versus nanomedicine, relies actually to a 
large extent on the bio-corona characteristics (Fadeel et al. 
2013). NPs can interact with proteins, membranes, cells, 
DNA and organelles and “generate” a nanoparticle–biolog-
ical interface. These are complex interactions that depend 
on colloidal forces as well as dynamic bio-physicochemical 
characteristics of the particle. The protein bio-corona will 
cover the nanoparticle, will define the intra-cellular uptake 
pathway and will in the end generate local, but as well as 
systemic processes balancing the thin thread of biocompat-
ibility versus bioadverse effects (Nel et al. 2009).
The initial characteristics of NP define the first level of 
interactions with biological molecules (Fig. 1). The char-
acteristic of protein attachment/detachment rates, various 
competitive biological binding interactions, steric hin-
drance induced by different polymeric structures and 
the protein profile of the body fluid(s) makes a dynamic 
bio-corona. The corona can change when particles move 
from one biological compartment to another, e.g., passing 
through cellular membrane to other intra-cellular compart-
ments. Potential changes in protein structure and function 
as a result of interacting with the NP surface can lead to 
potential molecular mechanisms of injury that could con-
tribute to disease pathogenesis.
Several groups have been lately studying the math-
ematical models to predict bio-corona formation (Li et al. 
2013). A mathematical model that describes the dynamics 
of nanoparticle corona complex formation was actually 
published. The model shows two phases of corona complex 
dynamics. In the first phase, there is a rapid protein binding 
to the free surface of NPs. During the second phase, there 
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is a continuous association and dissociation of protein mol-
ecules. Thus, in the biological environment, the NPs slowly 
modulate the composition of their bio-corona. Given suf-
ficient time, composition of the corona complex reaches 
an equilibrium state of stable composition. This recently 
suggested model shows that the dynamics of bio-corona 
formation constitute a vital aspect of interactions between 
NPs and living organisms. Moreover, authors pinpoint that 
modeling could better predict behavior for in vivo systems 
(Sahneh et al. 2013).
Continuing in this direction, the same group has 
recently shown that toxicology testing in animal models 
is extremely important. Indeed, assessing the impact of 
bio-corona kinetics on expected tissue distribution of NPs 
across species has shown that the potential fate of NPs 
in vivo is dependent upon basal metabolic rate. In other 
words, while engineered NPs can successfully reach tar-
get cells in rodent models, the results may be different in 
humans because an increased circulation time allows for 
further bio-corona evolution (Sahneh et al. 2015). From this 
point of view, time and space do matter. In other words, 
the chances for the immune system to detect a coated NP 
increase progressively with time.
As indicated in the introduction, after breaching the 
chemical–physical barrier, the innate immune system 
is the first line of defense. Cells of the innate immune 
branch are ready for microbial invasion as they are capa-
ble to recognize pathogen-associated molecular patterns 
(PAMPs) using pattern recognition receptors. The immune 
system also responds to the altered self, namely to tissue 
damage, a process triggered by the so-called danger- or 
damage-associated molecular patterns (DAMPs) or “alarm-
ins” (Fadeel 2012) (Fig. 2).
In addition to the self–non-self immune recognition, in 
the early 1994, the “danger” hypothesis was developed. 
In this aspect, the immune system is more concerned with 
entities that do damage than with those that are foreign. 
Thus, the primary driving force is the need to detect and 
protect against danger focusing more on endogenous than 
on exogenous signals. The cues represent the alarm signal 
that originates from an injured tissue (Matzinger 1994).
In the danger model, many of the PAMPs and DAMPs 
alarm signals may belong to an evolutionarily ancient 
alert system in which the hydrophobic portions of biologi-
cal molecules act, when exposed, as universal signals of 
damage to initiate immunity (Fadeel 2012). NPs can act 
as danger signals because pathogens display PAMPs and 
damaged tissues release DAMPs that act as a secreted 
alarmin; thus, engineered NPs coated with bio-corona of 
complex protein structure can act as nanomaterial-associ-
ated molecular patterns (NAMPs). These molecular sig-
natures are recognized by pattern recognition receptors 
(PRRs), including innate immunity Toll-like receptors. 
The activation of PRRs triggers inflammation and alerts 
the adaptive immune system to an imminent danger. Thus, 
NPs coated with bio-corona, displaying hydrophobic sur-
faces, are interpreted as danger signals by the immune sys-
tem. Indeed, Moyano et al. (2012) have shown in animal 
models that nanoparticle hydrophobicity dictates immune 
responses. These authors demonstrate that the gene 
expression profiling of mouse splenocytes exposed ex vivo 
to gold NPs is altered. Actually, the immune cells are 
Fig. 1  Bio-corona dynamics—A Chemical–physical characteristics 
of the particle induce the formation of the corona in a biological envi-
ronment. Proteins of different affinities reach the nanoparticle; the 
abundant particles (red dots) take the first row but are gradually dis-
placed by higher-affinity proteins (green and yellow dots); B an estab-
lished bio-corona will change its composition due to protein crowd-
ing and conformational changes (a), opsonization (b) and exposure of 
cryptic antigens that trigger antibodies interaction (c). In the end, a 
new bio-corona profile will appear, and hence, other biological effects 
are initiated (colour figure online)
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probably “blind” or at least “short sighted” to the naked 
NP surfaces (Moyano et al. 2012), while the bio-corona 
composition can initiate alternative immune patterns 
(Fig. 3). Thus, if the bio-corona composition can activate 
the components of the immune system like helper T lym-
phocytes type 1 (Th1), B lymphocytes and macrophages 
type 1 (M1), the entire panel of secreted molecules, start-
ing with Ig, cytokines and chemokines, will generate an 
acute inflammation reaction but not a prolonged one and 
hence no neoplastic events. On the other hand, if the bio-
corona activates Th2, M2 and regulatory T lymphocytes 
(Tregs), then the array of secreted molecules will sustain 
a chronic inflammation and hence possible pro-tumoral 
activity (Farrera and Fadeel 2015). Therefore, balancing of 
these two pathways is of utmost importance when NPs are 
intended for nanomedicine use.
Importantly, Nature has its own ways to try to bypass 
the action of immune cells. Thus, spores of the human 
opportunistic fungal pathogen Aspergillus fumigatus are 
surrounded by a natural protein corona of hydrophobin, 
making them “invisible” to cells of the immune system 
(Aimanianda et al. 2009). Using this property, hydro-
phobin-functionalized porous silicon NPs were shown to 
display a pronounced change in the degree of plasma pro-
tein adsorption in vitro and altered biodistribution in vivo 
when compared to uncoated NPs. This study provides fur-
ther evidence that “stealth” properties can be engineered 
by manipulating the bio-corona on NPs (Sarparanta et al. 
2012).
Bio‑corona inducing innate immunity
Unless they are specifically designed to avoid it, NPs are 
rapidly covered, in contact with biological fluids, by a 
selected group of biomolecules to form a corona that 
interacts with biological systems. As shown above, NP 
act as scaffold for biomolecules, which adsorb rapidly to 
the NPs’ surface and confer a new biological identity to 
the respective NPs (Monopoli et al. 2012). The dynamics 
of bio-corona formation constitute vital aspect of interac-
tions between NPs and living organisms. Initially, proteins 
rapidly bind to the free surface of NPs. During the second 
phase, continuous association and dissociation of protein 
molecules with NPs slowly change the composition of the 
corona complex. Finally, composition of the corona com-
plex reaches an equilibrium state of stable composition 
(Sahneh et al. 2013). Hence, proteins compete for the NP 
surface, generating a protein corona that is largely defined 
by the biological identity of the particle. In this respect, the 
knowledge of rates, affinities and stoichiometries of protein 
association with or dissociation from NPs is important for 
understanding the nature of the immunological response to 
the particles by the functional machinery of cells (Ceder-
vall et al. 2007a). In some cases, the protein corona may 
not fully saturate the surface area of nanoparticle and 
Fig. 2  Dendritic cell (DC)—key figure in immune activation. Recep-
tors on DC recognize damage-associated molecular patterns (DAMP), 
pathogen-associated molecular patterns (PAMPs) and nanoparticle-
associated molecular patterns (NAMPs) with pattern recognition 
receptors (PRR) like the Toll-like receptors family. Upon recogni-
tion, DCs can trigger direct inflammatory response, but by activating, 
T cells can likewise trigger adaptive immunity (adapted after Fadeel 
2012)
Fig. 3  Depending on the bio-corona composition, the same nanopar-
ticle can develop immune patterns that sustain pro- or anti-tumoral 
activities
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instead bind at discreet sites, leaving much of NP surface 
unobstructed, which could also affect its toxicity (Rybak-
Smith and Sim 2011). Bio-corona may extend the half-life 
of the NPs in systemic circulation by preventing the non-
specific uptake by cells of RES. Noteworthy, over seventy 
different serum proteins may heterogeneously be adsorbed 
to the surface of NPs. Variations in serum protein adsorp-
tion correlate with differences in the mechanism and effi-
ciency of NP uptake by a macrophage cell (Walkey et al. 
2012). Nuclear factor-kappaB (NF-кB)-dependent cytokine 
production in THP-1 monocyte cell line was one of the 
first reports regarding immune nanotoxicology, but the 
actual set of cytokines are different from one study to the 
other due to the different protein orientation and/or folding 
leading to different receptor activation and hence cytokine 
release (Deng et al. 2011), and, as presented in Fig. 3, 
different bio-corona compositions can portray discrete 
immune patterns.
The mononuclear phagocytic systems’ capabilities can 
be affected by the adsorption of surfactants or coatings pro-
tein, as in the case of uncoated nanospheres which form a 
complex with fibronectin and can be taken up by hepatic 
Kupffer cells (Dutta et al. 2007). In this manner, the num-
ber of binding sites on a NP is determined by the size of the 
particle as well as by the identity of the corona proteins. 
However, the hydrophobicity of the NP strongly influences 
its protein-binding properties (Cedervall et al. 2007a; Lind-
man et al. 2007). Biopersistent engineered nanomaterials 
activate innate immune responses via inflammasomes in 
macrophages, triggering IL-1beta release and neutrophilic 
infiltration (Thompson et al. 2014). On the other hand, pro-
teins coated on the surface of NPs may undergo conforma-
tional changes, resulting in the exposure of new epitopes 
which could be presented as antigen by antigen-presenting 
cells to initiate adaptive immune response (Nel et al. 2009). 
The NP surface may induce abnormal unfolding of the 
bound proteins to form novel conformational epitopes or 
may also induce unfolding of the native protein structure to 
expose hidden epitopes (Saptarshi et al. 2013). Such occult 
epitopes may affect the functionality of the bound proteins 
and lead to an unwanted immune response. Deng et al. 
(2011) showed that negatively charged poly(acrylic acid)-
conjugated gold NPs bound fibrinogen from blood plasma 
and induced its unfolding, which in turn activated the 
receptor macrophage-1 antigen (Mac-1) on THP-1 cells, 
causing release of inflammatory cytokines via the NF-κB 
pathway (Deng et al. 2011).
When performing a detailed identification of plasma 
protein binding to copolymer NPs, Cederval’s group in 
2009 showed that HSA, despite its higher concentration 
that is reflected by initially more abundant binding, is rap-
idly replaced by the higher-affinity and slower-exchang-
ing apolipoproteins AI, AII, AIV and E. Furthermore, 
high-density lipoproteins (HDLs) bind to copolymer NPs 
with much higher affinity than other lipoproteins, prob-
ably mediated by apolipoprotein A-I, which is its major 
component. In brief, together with the alternate protein-
binding patterns in the corona, copolymer NPs bind com-
plete HDL complexes and may be recognized by living sys-
tems as HDL complexes (Hellstrand et al. 2009). Albumin 
is the major protein adsorbed onto single-walled carbon 
nanotubes, whereas the targeting of albumin to scavenger 
receptors is well known. Targeting of the scavenger recep-
tor pathway by a single-walled carbon nanotubes—albu-
min—complex could result in interference with the innate 
immune response (Dutta et al. 2007). However, while com-
mon proteins can bind to different NPs, the biological out-
come may not be the same (Deng et al. 2013). Both pro-
tein’s structure and NP type contribute to bio-corona fate 
during intra-cellular uptake by target cells. Firstly, serum 
proteins are adsorbed onto the surface of NPs and protein 
structure can be modified during this step. For instance, 
a change in the secondary structure of BSA adsorbed on 
cationic polystyrene NPs forwards the protein–NP com-
plex to scavenger receptors of the target cell. By contrast, 
when NP is an anionic polystyrene type, the adsorbed BSA 
preserves its natural structure, causing the binding of BSA–
NPs complex to albumin receptors of target cells (Fleischer 
and Payne 2014). On negatively charged gold NPs, HSA 
has different behavior in relation to NPs concentration. At 
lower NPs concentrations, there is a higher affinity for tryp-
tophan, whereas at higher concentrations, both tryptophan 
and tyrosine residues participated in the interaction, without 
binding to the free sulfhydryl groups (Mariam et al. 2016). 
When NPs are fullerene, it was shown that HSA binds at 
the interfacial cavity formed by subdomains IIA and IIIA 
and that this bond is stabilized by van der Waals forces (Li 
et al. 2015). When investigating other blood proteins like 
fibrinogen, it was reported that on metal oxide NPs (TiO2, 
CeO2, Al2O3 and ZnO), fibrinogen interacted with TiO2 and 
CeO2 NPs with high affinity, while with Al2O3, the affinity 
was low and in an 1:1 ratio type. In contrast, HSA inter-
acted with TiO2, CeO2 and Al2O3 NPs with low affinity 
according to a conformational change model. Moreover, 
fibrinogen associated faster with NPs, while HSA exhibited 
a lower association pattern (Canoa et al. 2015).
Recent reports that used dynamic light scattering and 
nanoliquid chromatography tandem mass spectrometry 
for characterizing the bio-corona formed on lipid and sil-
ica NPs have shown that in contact with human plasma, 
the majority of adsorbed molecules are immunoglobulins, 
complement factors and coagulation proteins. All these bio-
molecules have specific receptors on immune cells which, 
upon their binding, results in cell activation (Caracciolo 
et al. 2015). On the other hand, other proteins like albu-
min and apolipoproteins can inhibit NPs uptake (Cedervall 
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et al. 2007a). Indeed, upon artificial coating of NPs, it was 
demonstrated that the uptake by macrophages is hindered 
(Caracciolo et al. 2015).
Higher exchange of IgG in serum proteins adsorbed to 
the nanostructured surfaces increases structural stability of 
IgG molecules adsorbed to nanostructured surfaces, while 
the sterical restrictions imposed by the nanostructure on 
the binding of IgG affect the interaction with complement 
proteins (Hulander et al. 2011). The immune complement 
system is part of the innate immune system, and one of its 
main functions is to act as a first line of defense against 
foreign objects; thus, when biomaterials come in contact 
with blood and other body fluids, complement incompat-
ibility reactions may occur (Nilsson et al. 2007; Remes and 
Williams 1992). The immune complement is comprised 
of more than 20 different proteins including activation 
and inhibition factors. Biomaterials are known agonists of 
complement and leukocyte activation (Gorbet and Sefton 
2004). Complement activation can occur though three path-
ways upon recognition of a target: classical, alternative 
and the lectin pathway. Complement activation by any of 
these pathways results in turnover of the complement pro-
tein C3, the production of inflammatory peptides C3a, C4a 
and C5a, as well as formation of C5b-9 complex or mem-
brane attack complex (Rybak-Smith and Sim 2011; Car-
roll and Sim 2011). The particle size or concentration at a 
specific conformational state of grafted polymer does not 
affect the complement activation on the NP surface. Upon 
defining the constituents of the protein corona on various 
NPs, it was shown that the elevated levels of two pro-com-
plement proteins, factors B and C3, are present on the NP 
surface grafted with glycopolymer chains that are respon-
sible for complement activity (Yu et al. 2014). The clas-
sical pathway is activated when the complement protein 
C1q binds to sufficient number of IgG molecules adsorbed 
on a surface (Hwang et al. 2008). Complement activation 
starts concomitantly with the adsorption of the protein film 
which is triggered by the self-limiting classical pathway 
activation. After adsorption of the protein film, alternative 
pathway activation provides the bulk of the C3b deposition 
that adds 25 % more mass to the surface (Andersson et al. 
2005). Although IgG fragments are found in the corona on 
all particles regardless of size or surface modification, the 
complement protein C1q is not found on the smaller than 
50-nm hydrophilic particles. However, on the unmodified 
(hydrophobic) particles, where C1q was found on all par-
ticles, this phenomenon does not apply (Lundqvist et al. 
2008). The C1q–IgG interaction activates the classical 
complement pathway leading to the generation of termi-
nal membrane attack complex (MAC) (Arlaud et al. 2002). 
The structure of the IgG binding domain of C1q consists of 
six globular heads that are equally distributed in a circle of 
approximately 20 nm in diameter (Kilchherr et al. 1985). 
Thus, in order to activate C1q, the required number of IgG 
molecules must be present within this diameter (Hulander 
et al. 2011; Gaboriaud et al. 2003). As the innate immune 
system plays a critical role in the protection against NPs, 
complement activation by nanotubes is consistent with 
adjuvant effects and might also promote damaging effects 
of excessive complement activation. C1q binds directly to 
carbon nanotubes. On the other hand, the protein binding 
to carbon nanotubes is highly selective. Thus, fibrinogen 
and apolipoproteins bound to carbon nanotubes in great-
est quantity (Salvador-Morales et al. 2006). The adhesion 
of functionalized carbon nanotubes to phagocytic cells and 
red blood cells may be altered by the interaction with com-
plement system proteins. However, excessive activation 
of complement can also cause harmful effects on adjacent 
human tissues (Rybak-Smith and Sim 2011). “Playing with 
the structure” in context of complement activation was 
accomplished by studying the roles of polystyrene NPs 
types in the initiation of the complement cascade. Interest-
ingly, alteration of copolymer architecture on nanospheres 
from “mushroom” to “brush” configuration not only 
switched complement activation from the C1q-dependent 
classical pathway to the so-called lectin pathway, but also 
reduced the level of generated complement activation prod-
ucts (Hamad et al. 2010).
Bio‑corona inducing acquired immunity
Actually, innate and adaptive immune responses work in 
harmony to provide efficient protection against invasion by 
foreign elements, not only by pathogens, but also by nano-
materials (Dumortier 2013). Innate immunity will shape 
the long-lived adaptive immune response mediated by T 
and B lymphocytes. PRR from the Toll-like receptor fam-
ily is one of the main innate immune molecules influencing 
adaptive immunity. This is orchestrated by DCs that effec-
tively present antigen to naïve T cells (Liu et al. 2013).
Subsequent to entrance into the body, nanomaterials 
encounter the immune system and may induce desirable 
or undesirable immunological effects (Dumortier 2013). In 
this respect, innate immune responses facilitate the partici-
pation of adaptive immune responses allowing the body to 
readily recognize damaged self-macromolecules, thereby 
increasing the efficiency of elimination. On the other hand, 
the adaptive immune system can produce a variety of 
signaling mediators which can stimulate and increase the 
effectiveness of the innate immune response (Wang et al. 
2013). Macrophages express opsonic and a range of non-
opsonic receptors, Toll-like receptors (TLRs), retinoic acid-
inducible gene I-like (RIG-I-like) and nucleotide-binding 
oligomerization domain-like (Nod-like) sensing receptors, 
on their surface as well as in vacuolar and cytosolic com-
partments. In macrophage activation: the first stage, 
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differentiation, depends on growth factors; the second, 
priming by interferon-gamma (IFN-γ) during the classi-
cal activation of macrophages or IL-4 and IL-13 during the 
alternative activation of macrophages; and the third stage, 
a localizing stimulus delivered by a TLR or analogous 
receptor. Exposure to metal oxide NPs or carbon nanotubes 
result in a Th1 immune cell microenvironment that pro-
motes the polarization of classically activated macrophages 
(Gordon and Martinez 2010). Eventually, NPs could mod-
ify macrophage phenotype (Ma et al. 2011). Thus, different 
metallic NPs may regulate innate and adaptive immunity in 
different directions by modulating dendritic cell functions. 
While some NPs potentiate human dendritic cells matura-
tion which favors Th-1 responses, the others may promote 
the secretion of anti-inflammatory cytokines by inducing 
antigen-presenting cells, leading to Th-2-dominated T cell 
profile (Schanen et al. 2013). This pronounced T helper 
response polarization resulting from metal oxide NPs could 
possibly be due to differences in the capacities of the NP 
species to regulate reactive oxygen species (ROS) pro-
duction. ROS are involved as the central second messen-
gers, acting at multiple levels in a multitude of the sign-
aling pathways that regulate the pro-inflammatory genes 
(Øvrevik et al. 2015). An increase in ROS production by 
NPs is an initiating step which has the capability to trig-
ger an innate immune response through the activation of 
the inflammasome (Wang et al. 2013). On the other hand, 
the key immunological responses related to multi-walled 
carbon nanotube exposure is NF-kB activation, leading to 
induction of ROS, thus resulting in the synergistic effect 
of systemic and local inflammation (Vitkina et al. 2016). 
Furthermore, metallo-fullerenol NPs can inhibit the growth 
of tumors by polarizing the cytokine balance toward Th-1 
type. Eventually, these particles trigger the host immune 
system by decreasing the production of Th-2 cytokines and 
increasing the production of Th1 type cytokines (Liu et al. 
2009).
Nanoparticles can definitely influence adaptive and 
innate immunity through their dynamic bio-corona, but 
there are still issues that need further clarifications, one of 
them being the pattern that guides adaptive immunity to 
trigger immunological memory.
Nanomedicine applications based on manipulating 
bio‑corona
Nanomedicine applications together with nanopharmaceu-
tics benefit from the rapidly advancing nanotechnology. 
Nanomedicine research and state-of-the-art advances in 
nanobiotechnology are closely linked. Research advances 
have brought high-tech nanoscale measurement that has 
facilitated the investigation of cellular biological processes; 
these investigations open the door for nanomedicine (Heico 
et al. 2012, NanoImpactNet). Current research in the field 
of nanomedicine is focused on how modulating the forma-
tion of bio-corona in complex biological environments can 
result in obtaining more targeted nanodrugs and in decreas-
ing rapid recognition by mononuclear phagocyte system 
(MPS) and the elimination of the NPs from the body.
Engineered NPs paired with a bio-corona have already 
been utilized both in in vitro and in vivo rodent models for 
pharmacokinetic purposes. However, in order to extrapolate 
these findings to human clinical trials, many physiological 
factors must be seriously considered, such as the protein 
nature of the corona, the species used for in vivo evalua-
tion, their basal metabolic rate, circulation blood levels 
and their size. Furthermore, the importance of the surface 
area of the body has already been demonstrated, showing 
the allometric relation of the conjugation and the cellular 
uptake (Eliasof et al. 2013). Based on this theory, several 
issues are raised regarding the distribution and the evolu-
tion of NPs–bio-corona complex inside the human body. 
In comparison with the animal models, the human’s body 
size and the circulation time needed are different; hence, 
extrapolating data from animal models to humans needs a 
cautious approach (Sahneh et al. 2015).
Nanomedicines are designed to interact with biologi-
cal systems at the nanoscale. Thus, the physicochemical 
properties of nanomaterials play important role as scaffolds 
for the bio-nanointerface. Bio-corona cannot be ignored 
in the design of nanomedicines, especially when they are 
composed of targeting ligands. Moreover, bio-coronas 
can enhance the effectiveness of NPs used as drug deliv-
ery vehicles by increasing their payload capacity (Hamad-
Schifferli 2015).
Sanchez-Moreno et al. (2015) studied in detail how 
the NP uptake and the therapeutic efficacy of the NPs are 
affected by adding a poloxamer in order to control corona 
formation. Four-lipid core–shell nanosystem with a hydro-
phobic core constituted by olive oil and hydrophilic shell 
by different composition (Pluronic F127 and Epikuron 
145 V) was reported. The nature and the concentration of 
the surfactant can control the interactions between lipid 
NPs and the biological environment. The blood circulation 
time of the NPs could be increased by adding a coating, like 
poloxomer, which leads to a lower uptake by macrophage 
through reducing unspecific binding, but this likewise 
attenuated the uptake into the target cells and decreased 
therapeutic efficacy (Sanchez-Moreno et al. 2015). In order 
to increase the recognition and uptake at the target sites, 
targeting moieties could be conjugated on these NPs (Rata-
Aguilar et al. 2012; Sanchez-Moreno et al. 2013).
Interactions with serum proteins endow NPs with the 
best bio-corona for nanomedicine applications (Lynch and 
Dawson 2008; Mahmoudi et al. 2011a, b). Yallapu et al. 
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(2015) showed that different adsorption patterns dictate 
the intended target. Apolipoprotein E (apoE) binding to 
magnetic nanoparticles (MNPs) led to enhanced transport 
across the blood–brain barrier. Protein binding to a lesser 
extent resulted in NPs targeting blood circulation, while an 
increased binding guided NPs toward liver and kidney. The 
same authors demonstrated that after the protein corona 
formation, MNPs undergo an uptake process that has an 
increased dynamics or an increased interaction with the 
membrane structures, enhancing the overall internalization 
process in cancer cell lines (Yallapu et al. 2015).
Human serum albumin and apoE are used to steadily 
form conjugates with polyelectrolyte multilayer-coated 
gold NP (AuNP) prior to intravenous injection. This coat-
ing influences the bio-corona formation and the NP bio-
kinetics. Albumin NPs exhibited increased accumulation 
in lungs, spleen and brain in comparison with the control 
cit-AuNP. Protein conjugation reduces also liver retention 
(Schäffler et al. 2014). The application of these findings 
may overcome some obstacles related to lung-directed ther-
apies and may present a starting point for the design of nan-
odrugs targeting tuberculosis and other lung diseases. They 
may also prove useful in designing nanoparticulate drugs 
intended to cross blood–brain barrier by manipulating the 
formation of bio-corona in vivo. Indeed, apolipoproteins 
conjugated with NPs promote the interaction between the 
NP with low-density lipoprotein receptors leading to an 
enhanced transport across the blood–brain barrier (Monop-
oli et al. 2011).
It is well established that the protein corona is affected 
by several factors including physiochemical properties of 
the NPs, temperature (Mahmoudi et al. 2013), protein con-
centration (Caracciolo et al. 2011; Monopoli et al. 2011), 
incubation time (Tenzer et al. 2013; Lundqvist 2013; 
Barran Berdon et al. 2013), as well as the protein source 
(serum vs plasma) or by animal source [mouse plasma 
(MP) vs human plasma (HP), etc.]. Thus, Caracciolo et al. 
(2014a, b) showed that MP liposomes are more enriched in 
apolipoproteins, less enriched in opsonins and more nega-
tively charged than HP liposomes. These findings suggest 
a different pharmacokinetic profile of liposomes in the 
bloodstream of humans compared to mice. Hajipour et al. 
(2014) have recently demonstrated that the pathological 
changes in different diseases can cause the formation of 
different protein corona. Thus, the concept of a “person-
alized protein corona” is a determinant factor for biologi-
cal and clinical applications. In another study, it has been 
shown that the cationic liposome–protein corona presented 
differences in zeta potential between healthy volunteers 
and histologically proven pancreatic cancer patients, with 
statistically significant reduction in the level of clinically 
relevant proteins (Caracciolo et al. 2014b). All these find-
ings led to the concept of manipulating the formation of 
protein corona to get targeted drugs and gene delivery using 
liposomes. The design of liposomes can provide the uptake 
of proteins in bio-corona that are specifically recognized 
by receptors expressed on target cells. Yokoe et al. (2008) 
showed that when albumin is conjugated to drug-loaded 
PEGylated liposomes, their blood circulation is enhanced 
along with their superior therapeutical action. These 
authors thus demonstrated that albumin decreased opsonin 
binding to PEGylated liposomes and that the therapeutic 
activity against sarcoma of doxorubicin-loaded liposomes 
is improved (Yokoe et al. 2008). A separate study showed 
that the serum proteins enhanced the binding of cationic 
NPs to the cells and inhibited the binding of anionic NP 
s. This behavior depends on cellular receptors targeted by 
these complexes between serum protein and NPs (Fleischer 
and Payne 2012).
Moreover, in regard to further biomedical approaches, 
the bio-nanocorona complex could open new horizons for 
research on the bio-nanointeractions, such as the interac-
tions with the cells of the innate and the adaptive immune 
system. As recently published, the engineered bio-corona 
NPs could prove to be very helpful tool for immunomodu-
lation, supporting fertile ground for better engineering and 
advanced design of immunologically safer target nanosys-
tems. Specifically, Fang et al. (2014) revealed a whole new 
delivery scenario, by designing a bio-complex of NPs to 
mimic red blood cells and thus to escape from the immune 
system. They combined biodegradable polymeric NPs with 
membrane lipids and membranes derived from blood cells 
and transformed them into efficient bio-carriers. Results 
indicated that even the delivery and the release of slowly 
biodegradable drugs had a better uptake with the use of bi-
mimetic carriers, as compared to the standard PEG “path-
way” (Fadeel et al. 2010; Nystrom and Fadeel 2012).
Another application with good future perspectives is 
vaccination. We have discussed in the previous sections that 
nanomaterials interact with innate immune cells through 
TLRs but as well as with other immune molecular systems 
such as the complement system. Nanomaterials that carry 
the complex bio-corona can activate the inflammasome in 
macrophages leading to pro-inflammatory cytokines cas-
cade. Importantly, these findings can be manipulated in 
developing novel classes of immunostimulatory agents 
(Hubbell et al. 2009). Cells of the innate immune arm can 
enzymatically digest nanomaterials based on carbon mate-
rials, resulting thus in materials that are cleared off from 
the organism and that are not persistent as asbestos fib-
ers. Therefore, one can imagine that carbon nanotubes can 
be good carriers for therapeutic agent’s delivery (Fadeel 
2012). The bio-corona on NP’s surfaces critically discrimi-
nates the biological responses and hence the involvement 
in any therapeutical approach. Danger signals described 
above and recently reviewed in bio-corona context (Farrera 
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and Fadeel 2015) can have therapeutically positive effects. 
Knowing that vaccine adjuvants (alum) used since the 
1920s (Mbow et al. 2011) enhance the immunogenicity of 
a co-administered antigen (De Gregorio et al. 2008) can 
shed new light on nanomaterials applications that could be 
extended as adjuvant carriers and/or deliver per se other 
adjuvants (Hubbell et al. 2009). Using pluronic-stabilized 
polypropylene sulfide (PPS) NPs conjugated to the model 
antigen OVA, the generation of humoral and cellular immu-
nity (Reddy et al. 2007) was demonstrated. In this model, 
the complement cascade was generated, engendering a 
“danger” signal that activated DCs. A typical vaccination 
reaction was obtained hence. Mice immunization with syn-
thetic NP, poly(d, l-lactic-co-glycolic acid) (PLGA) con-
taining antigen, plus ligands that activate TLR4 and TLR7 
can induce higher titers of antigen-specific, neutralizing 
antibodies compared to immunization with NPs specific for 
just one TLR. This model proved its usefulness in protect-
ing against lethal avian and swine influenza virus strains. 
This vaccination type was also tested in non-human pri-
mates that show a different TLR7 expression on DCs as 
we compared to murine strains (Kasturi et al. 2011). This 
vaccine resembling a virus both in size and in composition 
recapitulated the immunogenicity of live viral vaccines. 
Later on, a new NP-based toxin detainment was used for 
delivering pore-forming toxins. Mice vaccinated with the 
NP-detained toxin displayed superior protective immunity 
(Hu et al. 2013). Engineered NPs can go as far as artifi-
cial antigen-presenting cells, delivering antigen plus immu-
nostimulatory molecules for vaccination. NPs can mimic 
microorganisms like viruses, surpassing all the complica-
tions of recombinant viral vaccines (Moon et al. 2011, 
2012). Delivering antigens to antigen-presenting cells was 
reported several years ago (Dumortier 2013; Villa et al. 
2011). Single-walled carbon nanotubes were used as car-
riers for delivery of peptides into antigen-presenting cells 
and were able to induce IgGs against weak tumor-asso-
ciated antigens. More recently, the utilization of PEG-
modified single-walled carbon nanotubes armed with the 
glucocorticoid-induced TNFR-related receptor (GITR) 
demonstrated in vivo targeting of regulatory T cells resid-
ing in a B16 melanoma in mice (Sacchetti et al. 2013).
It is well established that certain small molecules, non-
immunogenic haptens, can elicit an immune response when 
coupled to a protein carrier (Boraschi et al. 2012). Thus, 
immunization of mice with a C60 fullerene derivative con-
jugated to bovine thyroglobulin yielded IgG antibodies spe-
cific to fullerenes (Chen et al. 1998). Different classes of 
NPs are promising tools for immunomodulation, but their 
long-term safety needs to be examined in the course to clin-
ical translation. Nevertheless, NPs’ bio-corona can induce 
specific immune responses, which presents further biologi-
cal ground for future nanomedicine applications.
Toxicological particularities of NPs’ protein 
bio‑corona
Several aspects within this section were touched upon 
in the previous sections, but some final highlights of the 
toxicological aspects that are raised by the protein bio-
corona need to be resolved. Due to NPs’ physical charac-
teristics and high surface area–volume ratio, there remain 
unknown toxicity mechanisms within the biological sys-
tems that remain to be unraveled (Oberdorster 2010). 
Several recent studies have shown that bio-corona clearly 
induces cellular responses. Thus, p38 MAPKs which are 
stress-activated kinases are recently shown to be induced 
by positively charged mesoporous silica NPs, whereas 
negatively charged NPs induce ROS. However, when NPs 
were coated with proteins, their cellular deleterious effect 
was significantly reduced (Liu et al. 2015). Inflamma-
tory responses, portrayed by the activation of IL-6, can be 
induced by AgNPs with or without a protein corona (Shan-
nahan et al. 2015). As discussed in the previous sections, 
single-walled carbon nanotubes bind different blood pro-
teins and were shown to induce different cytotoxicity issues 
(Ge et al. 2011), while graphene oxide covered with a pro-
tein corona was less cytotoxic compared to naked ones (Hu 
et al. 2011). There is a turn in the story when we analyze 
the immune response developed by bio-corona covered 
NPs. Proteins that comprise the bio-corona, IgG, comple-
ment, albumins, lipoproteins, and so on, can generate cel-
lular immune response leading up to inflammation (Sim 
and Wallis 2011). Overcoming this impediment relies on a 
controlled NP’s surface composition and hence controlled 
biomolecules absorption (Hulander et al. 2011; Bertholon 
et al. 2006).
As indicated above, the bio-corona is a dynamic entity 
and the toxicological impact of it needs to be determined 
by unveiling toxicologically relevant phenomena at the 
nano-bio-interface (Westmeier et al. 2015). Concentrat-
ing on the future of nanotoxicology in this framework, 
Westmeier et al. (2015) have outlined some important 
directions to follow. Thus, highly advanced in vitro cel-
lular models should reproduce the major entry routes 
of NPs to biological systems, in order to sustain high-
throughput analysis and standardization. Another modal-
ity important in resolving the toxicological issues for 
inter-cellular communication, intra-/inter-cellular signal-
ing pathways and complex responses to NPs is to go up 
to organ-on-a chip (Lancaster et al. 2013; Nguyen et al. 
2013; Westmeier et al. 2015). In vitro testing should 
advance to in vivo models where predictability of NPs’ 
influence on human health needs to be examined (Nel 
et al. 2013). Although there are various NPs toxicology 
animal models, a highly specific animal model for bio-
corona research is still to be developed (Westmeier et al. 
1044 Arch Toxicol (2017) 91:1031–1048
1 3
2015). Moreover, it must be stressed that in nanotoxicol-
ogy issues, the mere evaluation of cell’s viability is not 
sensitive enough to unveil the complex processes of bio-
corona formation in vivo and hence to predict NPs fate in 
a complex biological system.
Conclusion
Understanding the complex interaction of NPs with the 
biological microenvironments of the host organism and the 
resulting biological actions is one of the goals of nanotoxi-
cology and the nanomedicine field. All the physicochemi-
cal properties that characterize NPs alter the immune 
interactions. Specific adsorption of biomolecules bestows 
onto the NP a new immunological identity (Fadeel 2012). 
Understanding the subtle kinetics of the bio-corona forma-
tion process can be seminal in predicting NP behavior in 
biological systems, including applications of nanotoxicol-
ogy and development of nanodrug delivery platforms. As 
NPs are in the size range of biological aggressors, inter-
actions with the immune system are more likely to occur 
(Dobrovolskaia and McNeil 2007; Andón and Fadeel 
2013; Shvedova et al. 2010). Indeed, immune recogni-
tion of microbial molecules (Kono and Rock 2008) can 
be activated in NPs immune recognition. In this light, 
nanomaterials able to interact with the immune cells are 
of utmost importance in terms of biological activity (Shve-
dova et al. 2010). Noteworthily, NPs entering the organ-
ism develop a specific bio-corona comprising complex 
and dynamic layers of biomolecules that endow NPs with 
a new immunological identity. Understanding how the 
nanomaterial interacts with its biological surroundings is 
of utmost importance, and its application can specifically 
target novel nanodrugs not only at the systemic scale, but 
as well as to the level of intra-cellular compartments (Con-
stantin et al. 2010; Socoteanu et al. 2015). In this light, 
engineered nanomaterials can be tailored for “smart” drug 
delivery with applications that start from in vivo imaging 
and go to regenerative medicine.
Pinpointing individual nanomaterial characteristics 
(Fadeel et al. 2013) can foresee the biological and medi-
cal fate of the nanodrug (Fadeel et al. 2015). NPs can 
cross biological barriers, thus making them perfect drug 
delivery systems, but the further fate of NPs, e.g., excre-
tion, biodegradation, accumulation or any other long-term 
non-immune/immune processes, should be clearly under-
stood while developing safer nanomedicines (Nystrom and 
Fadeel 2012).
Acknowledgments Monica Neagu and Carolina Constantin were 
partially supported by Research Grants PCE-ID-PCE-2011-3-0918 
and PN-II-PT-PCCA-2013-4-1386 (Nanopatch).
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theo-
charis AD, Pavao MS, Tzanakakis GN, Karamanos NK (2012) 
Glycosaminoglycans: key players in cancer cell biology and 
treatment. FEBS J 279:1177–1197
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil 
SE (2009) Nanoparticle interaction with plasma proteins as it 
relates to particle biodistribution, biocompatibility and thera-
peutic efficacy. Adv Drug Deliv Rev 61:428–437
Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru 
SR et al (2009) Surface hydrophobin prevents immune recogni-
tion of airborne fungal spores. Nature 460:1117–1121
Andersson J, Ekdahl KN, Lambris JD, Nilsson B (2005) Binding of 
C3 fragments on top of adsorbed plasma proteins during com-
plement activation on a model biomaterial surface. Biomaterials 
26(13):1477–1485
Andón FT, Fadeel B (2013) Programmed cell death: molecular mech-
anisms and implications for safety assessment of nanomaterials. 
Acc Chem Res 46(3):733–742
Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V (2002) Structural 
biology of C1. Biochem Soc Trans 30(Pt 6):1001–1006
Barran Berdon AL, Pozzi D, Caracciolo G, Capriotti AL, Caruso G, 
Cavaliere C et al (2013) Time evolution of nanoparticle-protein 
corona in human plasma: relevance for targeted drug delivery. 
Langmuir 29:6485–6494
Bertholon I, Vauthier C, Labarre D (2006) Complement activation by 
core-shell poly(isobutylcyanoacrylate)-polysaccharide nano-
particles: influences of surface morphology, length, and type of 
polysaccharide. Pharm Res 23:1313–1323
Boraschi D, Costantino L, Italiani P (2012) Interaction of nanopar-
ticles with immunocompetent cells: nanosafety considerations. 
Nanomedicine (Lond) 7:121–131
Bouris P, Skandalis SS, Piperigkou Z, Afratis N, Karamanou K, Ale-
tras AJ, Moustakas A, Theocharis AD, Karamanos NK (2015) 
Estrogen receptor alpha mediates epithelial to mesenchymal 
transition, expression of specific matrix effectors and functional 
properties of breast cancer cells. Matrix Biol 43:42–60
Canoa P, Simón-Vázquez R, Popplewell J, González-Fernández Á 
(2015) A quantitative binding study of fibrinogen and human 
serum albumin to metal oxide nanoparticles by surface plasmon 
resonance. Biosens Bioelectron 74:376–383
Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Foglia P, Amen-
itsch H et al (2011) Evolution of the protein corona of lipid 
gene vectors as a function of plasma concentration. Langmuir 
27:15048–15053
Caracciolo G, Caputo D, Pozzi D, Colapicchioni V, Coppola R 
(2014a) Size and charge of nanoparticles following incubation 
with human plasma of healthy and pancreatic cancer patients. 
Colloids Surf B Biointerf 123:673–678
Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Piovesana S, La 
Barbera G et al (2014b) The liposome–protein corona in mice 
and humans and its implications for in vivo delivery. J Mater 
Chem B 2:7419–7428
Caracciolo G, Palchetti S, Colapicchioni V, Digiacomo L, Pozzi 
D, Capriotti AL et al (2015) Stealth effect of biomolecular 
1045Arch Toxicol (2017) 91:1031–1048 
1 3
corona on nanoparticle uptake by immune cells. Langmuir 
31(39):10764–10773
Carroll MV, Sim RB (2011) Complement in health and disease. Adv 
Drug Deliv Rev 63(12):965–975
Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, 
Dawson KA, Linse S (2007a) Understanding the nanoparticle-
protein corona using methods to quantify exchange rates and 
affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 
104:2050–2055
Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, 
Linse S, Dawson KA (2007b) Detailed identification of plasma 
proteins adsorbed on copolymer nanoparticles. Angew Chem 
Int Ed Engl 46(30):5754–5756
Chen BX, Wilson SR, Das M, Coughlin DJ, Erlanger BF (1998) Anti-
genicity of fullerenes: antibodies specific for fullerenes and 
their characteristics. Proc Natl Acad Sci USA 95:10809–10813
Constantin C, Neagu M, Ion R-M, Gherghiceanu M, Stavaru C (2010) 
Fullerene-porphyrin nanostructures in photodynamic therapy. 
Nanomedicine 5(2):307–317
Cox MC, Barnham KJ, Frenkiel TA, Hoeschele JD, Mason AB, He 
Q-Y et al (1999) Identification of platination sites on human 
serum transferrin using 13C and 15 N NMR spectroscopy. 
JBIC, J Biol Inorg Chem 4(5):621–631
Danilova N (2008) Evolution of the human immune system. In: 
Encyclopedia of life sciences (ELS). Wiley, Chichester. 
doi:10.1002/9780470015902.a0020781)
Danilova N (2013) Evolution of the human immune system. In: eLS. 
Wiley, Chichester. doi:10.1002/9780470015902.a0020781.pub2
De Gregorio E, Tritto E, Rappuoli R (2008) Alum adjuvanticity: 
unraveling a century old mystery. Eur J Immunol 38:2068–2071
De Las Rivas J, Fontanillo C (2010) Protein–protein interactions 
essentials: key concepts to building and analyzing interactome 
networks. PLoS Comput Biol 6(6):e1000807
Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin 
RF (2009) Differential plasma protein binding to metal oxide 
nanoparticles. Nanotechnology 20(45):455101
Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF (2011) Nanopar-
ticle-induced unfolding of fibrinogen promotes Mac-1 receptor 
activation and inflammation. Nat Nano 6:39–44
Deng ZJ, Liang M, Toth I, Monteiro M, Minchin RF (2013) Plasma 
protein binding of positively and negatively charged polymer-
coated gold nanoparticles elicits different biological responses. 
Nanotoxicology 7(3):314–322
Dobrovolskaia MA, McNeil SE (2007) Immunological properties of 
engineered nanomaterials. Nat Nanotechnol 2:469–478
Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggar-
wal P, Neun BW, Hall JB, McNeil SE (2009) Interaction of col-
loidal gold nanoparticles with human blood: effects on particle 
size and analysis of plasma protein binding profiles. Nanomed 
Nanotechnol Biol Med 5(2):106–117
Dobrovolskaia MA, Neun BW, Man S, Ye X, Hansen M, Patri AK, 
Crist RM, McNeil SE (2014) Protein corona composition does 
not accurately predict hematocompatibility of colloidal gold 
nanoparticles. Nanomedicine 10:1453–1463
Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher 
RC, Karlsson G, Edwards K, Kenner G, Samuels L, Webb MS, 
Bally MB (2007) Influence of poly(ethylene glycol) grafting 
density and polymer length on liposomes: relating plasma cir-
culation lifetimes to protein binding. Biochim Biophys Acta 
1768:1367–1377
Dumortier H (2013) When carbon nanotubes encounter the immune 
system: desirable and undesirable effects. Adv Drug Deliv Rev 
65(15):2120–2126
Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, 
Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, 
Weber TJ (2007) Adsorbed proteins influence the biological 
activity and molecular targeting of nanomaterials. Toxicol Sci 
100(1):303–315
Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdorster G, 
McGrath JL (2009) The influence of protein adsorption on nan-
oparticle association with cultured endothelial cells. Biomateri-
als 30(4):603–610
Eliasof S, Lazarus D, Peters CG, Case RI, Cole RO, Hwang J, 
Schluep T, Chao J, Lin J, Yen Y, Han H, Wiley DT, Zuckerman 
JE, Davis ME (2013) Correlating preclinical animal studies and 
human clinical trials of a multifunctional, polymeric nanoparti-
cle. Proc Natl Acad Sci USA 110(37):15127–15132
Engin AB, Neagu M, Golokhvast K, Tsatsakis A (2015) Nanoparti-
cles and endothelium: an update on the toxicological interac-
tions. Farmacia 63(6):792–804
Fadeel B (2012) Clear and present danger? Engineered nanoparticles 
and the immune system. Swiss Med Wkly 142:w13609
Fadeel B, Kasemo B, Malmsten M, Stromme M (2010) Nanomedi-
cine: reshaping clinical practice. J Intern Med 267:2–8
Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ (2013) 
Bridge over troubled waters: understanding the synthetic and 
biological identities of engineered nanomaterials. Wiley Inter-
discip Rev Nanomed Nanobiotechnol 5(2):111–129
Fadeel B, Fornara A, Toprak MS, Bhattacharya K (2015) Keeping it 
real: the importance of material characterization in nanotoxicol-
ogy. Biochem Biophys Res Commun S0006-291X(15):30207
Fang RH, Hu CM, Luk BT, Gao W, Copp J, Tai Y, O’Connor DE, Zhang 
L (2014) Cancer cell membrane-coated nanoparticles for antican-
cer vaccination and drug delivery. Nano Lett 14:2181–2188
Farrera C, Fadeel B (2015) It takes two to tango: understanding the 
interactions between engineered nanomaterials and the immune 
system. Eur J Pharm Biopharm 95((Part A)):3–12
Fleischer CC, Payne CK (2012) Nanoparticle surface charge mediates 
the cellular receptors used by protein–nanoparticle complexes. J 
Phys Chem B 116:8901–8907
Fleischer CC, Payne CK (2014) Nanoparticle–cell interactions: 
molecular structure of the protein corona and cellular outcomes. 
Acc Chem Res 47:2651–2659
Gaboriaud C, Juanhuix J, Gruez A, Lacroix M, Darnault C, Pignol 
D, Verger D, Fontecilla-Camps JC, Arlaud GJ (2003) The crys-
tal structure of the globular head of complement protein C1q 
provides a basis for its versatile recognition properties. J Biol 
Chem 278(47):46974–46982
Ge C, Du J, Zhao L, Wang L, Liu Y, Li D et al (2011) Binding of 
blood proteins to carbon nanotubes reduces cytotoxicity. Proc 
Natl Acad Sci USA 108(41):16968–16973
Gessner A, Waicz R, Lieske A, Paulke B, Mader K, Muller RH (2000) 
Nanoparticles with decreasing surface hydrophobicities: influ-
ence on plasma protein adsorption. Int J Pharm 196(2):245–249
Gessner A, Lieske A, Paulke BR, Müller RH (2002) Influence of sur-
face charge density on protein adsorption on polymeric nano-
particles: analysis by two-dimensional electrophoresis. Eur J 
Pharm Biopharm 54(2):165–170
Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix 
metalloproteinases in cancer progression and their pharmaco-
logical targeting. FEBS J 278:16–27
Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: 
roles of coagulation factors, complement, platelets and leuko-
cytes. Biomaterials 25(26):5681–5703
Gordon S, Martinez FO (2010) Alternative activation of macrophages: 
mechanism and functions. Immunity 32(5):593–604
Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S 
et al (2000) ‘Stealth’ corona-core nanoparticles surface modi-
fied by polyethylene glycol (PEG): influences of the corona 
(PEG chain length and surface density) and of the core com-
position on phagocytic uptake and plasma protein adsorption. 
Colloids Surf B Biointerf 18(3–4):301–313
1046 Arch Toxicol (2017) 91:1031–1048
1 3
Hajipour MJ, Laurent S, Aghaie A, Rezaee F, Mahmoudi M (2014) 
Personalized protein coronas: a “key” factor at the nanobioint-
erface. Biomater Sci 2:1210–1221
Hamad I, Al-Hanbali O, Hunter AC, Rutt KJ, Andresen TL, Moghimi 
SM (2010) Distinct polymer architecture mediates switching of 
complement activation pathways at the nanosphere-serum inter-
face: implications for stealth nanoparticle engineering. ACS 
Nano 4:6629–6638
Hamad-Schifferli K (2015) Exploiting the novel properties of protein 
coronas: emerging applications in nanomedicine. Nanomedi-
cine (Lond) 10:1663–1674
Heico J, Frima N, Gabellieri Cristina, Nilsson Maj-Inger (2012) Drug 
delivery research in the European Union’s Seventh Framework 
Programme for research. J Controll Release 161:409–415
Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlbäck B, Daw-
son KA, Linse S, Cedervall T (2009) Complete high-density 
lipoproteins in nanoparticle corona. FEBS J 276(12):3372–3381
Hill HD, Millstone JE, Banholzer MJ, Mirkin CA (2009) The role 
radius of curvature plays in thiolated oligonucleotide loading on 
gold nanoparticles. ACS Nano 3(2):418–424
Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N et al (2011) Protein 
corona-mediated mitigation of cytotoxicity of graphene oxide. 
ACS Nano 5:3693–3700
Hu CM, Fang RH, Luk BT, Zhang L (2013) Nanoparticle-detained 
toxins for safe and effective vaccination. Nat Nanotechnol 
8:933–938
Hubbell JA, Thomas SN, Swartz MA (2009) Materials engineering 
for immunomodulation. Nature 462:449–460
Hulander M, Lundgren A, Berglin M, Ohrlander M, Lausmaa J, 
Elwing H (2011) Immune complement activation is attenuated 
by surface nanotopography. Int J Nanomed 6:2653–2666
Hwang HY, Duvall MR, Tomlinson S, Boackle RJ (2008) Highly spe-
cific inhibition of C1q globular-head binding to human IgG: a 
novel approach to control and regulate the classical complement 
pathway using an engineered single chain antibody variable 
fragment. Mol Immunol 45(9):2570–2580
Janeway CA Jr (1992) The immune system evolved to discriminate 
infectious nonself from non-infectious self. Immunol Today 
13(1):11–16
Karamanos NK, Tzanakakis GN (2012) Glycosaminoglycans: from 
“cellular glue” to novel therapeutical agents. Curr Opin Phar-
macol 12:220–222
Karmali PP, Simberg D (2011) Interactions of nanoparticles with 
plasma proteins: implication on clearance and toxicity of drug 
delivery systems. Expert Opin Drug Deliv 8:343–357
Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, 
Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, Vil-
linger F, Murthy N, Steel J, Jacob J, Hogan RJ, García-Sastre A, 
Compans R, Pulendran B (2011) Programming the magnitude 
and persistence of antibody responses with innate immunity. 
Nature 470:543–547
Kilchherr E, Hofmann H, Steigemann W, Engel J (1985) Structural 
model of the collagen-like region of C1q comprising the kink 
region and the fibre-like packing of the six triple helices. J Mol 
Biol 186(2):403–415
Kono H, Rock KL (2008) How dying cells alert the immune system to 
danger. Nat Rev Immunol 8:279–289
Lacerda SHDP, Park JJ, Meuse C, Pristinski D, Becker ML, Karim 
A et al (2009) Interaction of gold nanoparticles with common 
human blood proteins. ACS Nano 4(1):365–379
Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles 
ME et al (2013) Cerebral organoids model human brain devel-
opment and microcephaly. Nature 501:373–379
Li R, Chen R, Chen P, Wen Y, Ke PC, Cho SS (2013) Computational 
and experimental characterizations of silver nanoparticle-apoli-
poprotein bio-corona. J Phys Chem B 117:13451–13456
Li J, Jiang L, Zhu X (2015) Computational studies of the binding 
mechanisms of fullerenes to human serum albumin. J Mol 
Model 21(7):177
Lindman S, Lynch I, Thulin E, Nilsson H, Dawson KA, Linse S 
(2007) Systematic investigation of the thermodynamics of HSA 
adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide 
copolymer nanoparticles. Effects of particle size and hydropho-
bicity. Nano Lett 7:914–920
Liu Y, Jiao F, Qiu Y, Li W, Lao F, Zhou G, Sun B, Xing G, Dong J, 
Zhao Y, Chai Z, Chen C (2009) The effect of Gd@C82(OH)22 
nanoparticles on the release of Th1/Th2 cytokines and induc-
tion of TNF-alpha mediated cellular immunity. Biomaterials 
30(23–24):3845–3934
Liu D, Rhebergen AM, Eisenbarth SC (2013) Licensing adaptive 
immunity by NOD-like receptors. Front Immunol. Mol Innate 
Immun 4(486):2
Liu TP, Wu SH, Chen YP, Chou CM, Chen CT (2015) Biosafety 
evaluations of well-dispersed mesoporous silica nanoparticles: 
towards in vivo-relevant conditions. Nanoscale 7:6471–6480
Lundqvist M (2013) Nanoparticles: tracking protein corona over time. 
Nat Nanotechnol 8:701–702
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA 
(2008) Nanoparticle size and surface properties determine 
the protein corona with possible implications for biological 
impacts. Proc Natl Acad Sci USA 105:14265–14270
Lundqvist M, Stigler J, Cedervall T, Berggard T, Flanagan MB, Lynch 
I, Elia G, Dawson K (2011) The evolution of the protein corona 
around nanoparticles: a test study. ACS Nano 5:7503–7509
Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano 
Today 3:40–47
Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) 
Protein—nanoparticle interactions: opportunities and chal-
lenges. Chem Rev 111(9):5610–5637
Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, Schwegler-
Berry D, Castranova V, Ma JK (2011) Cerium oxide nanoparti-
cle-induced pulmonary inflammation and alveolar macrophage 
functional change in rats. Nanotoxicology 5(3):312–325
Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, 
Laurent S (2011a) Protein-nanoparticle interactions: opportuni-
ties and challenges. Chem Rev 111:5610–5637
Mahmoudi M, Sahraian MA, Shokrgozar MA, Laurent S (2011b) 
Superparamagnetic iron oxide nanoparticles: promises for diag-
nosis and treatment of multiple sclerosis. ACS Chem Neurosci 
2(3):118–140
Mahmoudi M, Abdelmonem AM, Behzadi S, Clement JH, Dutz S, 
Ejtehadi MR et al (2013) Temperature: the “ignored” factor at 
the NanoBio interface. ACS Nano 7:6555–65562
Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingo-
lani R et al (2010) Effects of cell culture media on the dynamic 
formation of protein—nanoparticle complexes and influence on 
the cellular response. ACS Nano 4(12):7481–7491
Mariam J, Sivakami S, Dongre PM (2016) Elucidation of structural 
and functional properties of albumin bound to gold nanoparti-
cles. J Biomol Struct Dyn 34(8):1–12
Matzinger P (1994) Tolerance, danger, and the extended family. Annu 
Rev lmmunol 12:991–1045
Mbow ML, De Gregorio E, Ulmer JB (2011) Alum’s adjuvant action: 
grease is the word. Nat Med 17:415–416
Mizumoto S, Sugahara K (2013) Glycosaminoglycans are functional 
ligands for receptor for advanced glycation end-products in 
tumors. FEBS J 280:2462–2470
Moghimi SM, Muir I, Illum L, Davis SS, Kolb-Bachofen V (1993) 
Coating particles with a block co-polymer (poloxamine-908) 
suppresses opsonization but permits the activity of dysopsonins 
in the serum. Biochim Biophys Acta (BBA) Mol Cell Res 
1179(2):157–165
1047Arch Toxicol (2017) 91:1031–1048 
1 3
Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli 
Bombelli F et al (2011) Physical–chemical aspects of protein 
corona: relevance to in vitro and in vivo biological impacts of 
nanoparticles. J Am Chem Soc 133:2525–2534
Monopoli MP, Aberg C, Salvati A, Dawson KA (2012) Biomolecular 
coronas provide the biological identity of nanosized materials. 
Nat Nanotechnol 7:779–786
Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, Sohail 
M, Luo S, Um SH, Khant H, Goodwin JT, Ramos J, Chiu W, 
Irvine DJ (2011) Interbilayer-crosslinked multilamellar vesicles 
as synthetic vaccines for potent humoral and cellular immune 
responses. Nat Mater 10:243–251
Moon JJ, Huang B, Irvine DJ (2012) Engineering nano- and micro-
particles to tune immunity. Adv Mater 24:3724–3746
Moyano DF, Goldsmith M, Solfiell DJ, Landesman-Milo D, Miranda 
OR, Peer D et al (2012) Nanoparticle hydrophobicity dictates 
immune response. J Am Chem Soc 134:3965–3967
Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P et al 
(2009) Understanding biophysicochemical interactions at the 
nano-bio interface. Nat Mater 8(7):543–557
Nel A, Zhao Y, Madler L (2013) Environmental health and safety con-
siderations for nanotechnology. Acc Chem Res 46:605–606
Nguyen TA, Yin TI, Reyes D, Urban GA (2013) Microfluidic chip 
with integrated electrical cell-impedance sensing for monitoring 
single cancer cell migration in three-dimensional matrixes. Anal 
Chem 85:11068–11076
Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) The role of 
complement in biomaterial-induced inflammation. Mol Immu-
nol 44(1–3):82–94
Nystrom AM, Fadeel B (2012) Safety assessment of nanomaterials: 
implications for nanomedicine. J Control Release 161:403–408
Oberdorster G (2010) Safety assessment for nanotechnology and 
nanomedicine: concepts of nanotoxicology. J Intern Med 
267:89–105
Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: 
an emerging discipline evolving from studies of ultrafine parti-
cles. Environ Health Perspect 113(7):823–839
Øvrevik J, Refsnes M, Låg M, Holme JA, Schwarze PE (2015) Acti-
vation of proinflammatory responses in cells of the airway 
mucosa by particulate matter: oxidant- and non-oxidant-medi-
ated triggering mechanisms. Biomolecules 5(3):1399–1440
Perry JL, Reuter KG, Kai MP, Herlihy KP, Jones SW, Luft JC et al 
(2012) PEGylated PRINT nanoparticles: the impact of PEG 
density on protein binding, macrophage association, biodistri-
bution, and pharmacokinetics. Nano Lett 12(10):5304–5310
Piperigkou Z, Karamanou K, Afratis N, Bouris P, Gialeli C, Belmiro 
CL et al (2016a) Biochemical and toxicological evaluation of 
nano-heparins in cell functional properties, proteasome acti-
vation and expression of key matrix molecules. Toxicol Lett 
240:32–42
Piperigkou Z, Karamanou K, Engin AB, Gialeli C, Docea AO, Vynios 
DH et al (2016b) Emerging aspects of nanotoxicology in health 
and disease: from agriculture and food sector to cancer thera-
peutics. Food Chem Toxicol 91:42–57
Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, 
Palchetti S, De Grossi S, Riccioli A, Amenitsch H, Lagana A 
(2014) Effect of polyethyleneglycol (PEG) chain length on the 
bio-nano-interactions between PEGylated lipid nanoparticles 
and biological fluids: from nanostructure to uptake in cancer 
cells. Nanoscale 6:2782–2792
Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M (2013) Nan-
oparticle and protein corona. In: Protein-nanoparticle interac-
tions. Springer, New York, pp 21–44
Rata-Aguilar A, Sanchez-Moreno P, Jodar-Reyes AB, Martin-Rod-
riguez A, Boulaiz H, Marchal-Corrales JA, Peula-Garcia JM, 
Ortega-Vinuesa JL (2012) Colloidal stability and “in vitro” 
antitumor targeting ability of lipid nanocapsules coated by 
folate–chitosan conjugates. J Bioact Compat Polym 27:388–404
Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, Oneil 
CP, Lee LK, Swartz MA, Hubbell JA (2007) Exploiting lym-
phatic transport and complement activation in nanoparticle vac-
cines. Nat Biotechnol 25:1159–1164
Remes A, Williams DF (1992) Immune response in biocompatibility. 
Biomaterials 13(11):731–743
Roach P, Farrar D, Perry CC (2005) Interpretation of protein adsorp-
tion: surface induced conformational changes. J Am Chem Soc 
127(22):8168–8173
Rybak-Smith MJ, Sim RB (2011) Complement activation by carbon 
nanotubes. Adv Drug Deliv Rev 63(12):1031–1041
Sacchetti C, Rapini N, Magrini A, Cirelli E, Bellucci S, Mattei M, 
Rosato N, Bottini N, Bottini M (2013) In vivo targeting of intra-
tumor regulatory T cells using PEG-modified single-walled car-
bon nanotubes. Bioconjug Chem 24:852–858
Saha K, Moyano DF, Rotello VM (2014) Protein coronas suppress the 
hemolytic activity of hydrophilic and hydrophobic nanoparti-
cles. Mater Horiz 2014:102–105
Sahneh DF, Scoglio C, Riviere J (2013) Dynamics of nanoparticle-
protein corona complex formation: analytical results from pop-
ulation balance equations. PLoS One 8(5):e64690
Sahneh FD, Scoglio CM, Monteiro-Riviere NA, Riviere JE (2015) 
Predicting the impact of bio-corona formation kinetics on inter-
species extrapolations of nanoparticle biodistribution modeling. 
Nanomedicine (Lond) 10:25–33
Salvador-Morales C, Flahaut E, Sim E, Sloan J, Green ML, Sim RB 
(2006) Complement activation and protein adsorption by car-
bon nanotubes. Mol Immunol 43(3):193–201
Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hris-
tov DR, Kelly PM, Aberg C, Mahon E, Dawson KA (2013) 
Transferrin-functionalized nanoparticles lose their targeting 
capabilities when a biomolecule corona adsorbs on the surface. 
Nat Nanotechnol 8:137–143
Sanchez-Moreno P, Ortega-Vinuesa JL, Boulaiz H, Marchal JA, 
Peula- Garcia JM (2013) Synthesis and characterization of lipid 
immuno-nanocapsules for directed drug delivery: selective anti-
tumor activity against HER2 positive breast-cancer cells. Bio-
macromolecules 14:4248–4259
Sanchez-Moreno P, Buzon P, Boulaiz H, Peula-García JM, Ortega-
Vinuesa JL, Luque I, Salvati A, Marchal JA (2015) Balancing 
the effect of corona on therapeutic efficacy and macrophage 
uptake of lipid nanocapsules. Biomaterials 61:266–278
Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparti-
cles with proteins: relation to bio-reactivity of the nanoparticle. 
J Nanobiotechnol 11:26
Sarparanta M, Bimbo LM, Rytkönen J, Mäkilä E, Laaksonen TJ, 
Laaksonen P et al (2012) Intravenous delivery of hydrophobin-
functionalized porous silicon nanoparticles: stability, plasma 
protein adsorption and biodistribution. Mol Pharm 9:654–963
Schäffler M, Sousa F, Wenk A, Sitia L, Hirn S, Schleh C, Haberl 
N, Violatto M, Canovi M, Andreozzi P, Salmona M, Bigini P, 
Wolfgang GK, Krol S (2014) Blood protein coating of gold 
nanoparticles as potential tool for organ targeting. Biomaterials 
35:3455–3466
Schanen BC, Das S, Reilly CM, Warren WL, Self WT, Seal S, Drake 
DR 3rd (2013) Immunomodulation and T helper TH1/TH2 
response polarization by CeO2 and TiO2 nanoparticles. PLoS 
One 8(5):e62816
Shannahan JH, Podila R, Aldossari AA, Emerson H, Powell BA, Ke 
PC et al (2015) Formation of a protein corona on silver nano-
particles mediates cellular toxicity via scavenger receptors. 
Toxicol Sci Off J Soc Toxicol 143:136–146
Shaw CP, Middleton DA, Volk M, Levy R (2012) Amyloid-derived 
peptide forms self-assembled monolayers on gold nanoparticle 
1048 Arch Toxicol (2017) 91:1031–1048
1 3
with a curvature-dependent beta-sheet structure. ACS Nano 
6:1416–1426
Shvedova AA, Kagan VE, Fadeel B (2010) Close encounters of the 
small kind: adverse effects of man-made materials interfacing 
with the nano-cosmos of biological systems. Annu Rev Pharma-
col Toxicol 50:63–88
Sim RB, Wallis R (2011) Surface properties: immune attack on nano-
particles. Nat Nanotechnol 6:80–81
Sisco PN, Wilson CG, Chernak D, Clark JC, Grzincic EM, Ako-Asare 
K, Goldsmith EC, Murphy CJ (2014) Adsorption of cellular 
proteins to polyelectrolyte-functionalized gold nanorods: a 
mechanism for nanoparticle regulation of cell phenotype? PLoS 
One 9:e86670
Socoteanu R, Anastasescu M, Oliveira A, Dobrescu G, Boscencu R, 
Constantin C (2015) Aggregation behavior of some asymmetric 
porphyrins versus basic biological tests response. Int J Photoen-
ergy 5:1–11
Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, 
Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, 
Schild H, Maskos M, Knauer SK, Stauber RH (2013) Rapid 
formation of plasma protein corona critically affects nanoparti-
cle pathophysiology. Nat Nanotechnol 8:772–781
Theocharis AD, Skandalis SS, Neill T, Multhaupt HA, Hubo M, Frey 
H, Gopal S, Gomes A, Afratis N, Lim HC, Couchman JR, Fil-
mus J, Sanderson RD, Schaefer L, Iozzo RV, Karamanos NK 
(2015) Insights into the key roles of proteoglycans in breast 
cancer biology and translational medicine. Biochim Biophys 
Acta 1855:276–300
Thompson EA, Sayers BC, Glista-Baker EE, Shipkowski KA, Tay-
lor AJ, Bonner JC (2014) Innate immune responses to nano-
particle exposure in the lung. J Environ Immunol Toxicol 
1(3):150–156
Vertegel AA, Siegel RW, Dordick JS (2004) Silica nanoparticle size 
influences the structure and enzymatic activity of adsorbed 
lysozyme. Langmuir 20(16):6800–6807
Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, 
Korontsvit T, Zakhaleva V, Batt CA, Philips MR, Scheinberg 
DA (2011) Single-walled carbon nanotubes deliver peptide anti-
gen into dendritic cells and enhance IgG responses to tumor-
associated antigens. ACS Nano 5:5300–5311
Vitkina TI, Yankova VI, Gvozdenko TA, Kuznetsov VL, Krasnikov 
DV, Nazarenko AV et al (2016) The impact of multi-walled 
carbon nanotubes with different amount of metallic impurities 
on immunometabolic parameters in healthy volunteers. Food 
Chem Toxicol 87:138–147
Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA 
(2010) What the cell “sees” in bionanoscience. J Am Chem Soc 
132(16):5761–5768
Walkey CD, Olsen JB, Guo H, Emili A, Chan WC (2012) Nanoparti-
cle size and surface chemistry determine serum protein adsorp-
tion and macrophage uptake. J Am Chem Soc 134:2139–2147
Wang X, Reece SP, Brown JM (2013) Immunotoxicological impact of 
engineered nanomaterial exposure: mechanisms of immune cell 
modulation. Toxicol Mech Methods 23(3):168–177
Westmeier D, Chunying Chen C, Stauber RH, Docter D (2015) 
The bio-corona and its impact on nanomaterial toxicity. Eur J 
Nanomed 7(3):153–168
European network on the health and environmental impact of nano-
materials (NanoImpactNet). www.nanoimpactnet.eu
Yallapu MM, Chauhan N, Othman SF, Khalilzad-Sharghi V, Ebeling 
MC, Khan S, Jaggi M, Chauhan SC (2015) Implications of pro-
tein corona on physico-chemical and biological properties of 
magnetic nanoparticles. Biomaterials 46:1–12
Yokoe J-i, Sakuragi S, Yamamoto K, Teragaki T, K-i Ogawara, Higaki K 
et al (2008) Albumin-conjugated PEG liposome enhances tumor 
distribution of liposomal doxorubicin in rats. Int J Pharm 353:28–34
Yu K, Lai BF, Foley JH, Krisinger MJ, Conway EM, Kizhakkedathu 
JN (2014) Modulation of complement activation and amplifica-
tion on nanoparticle surfaces by glycopolymer conformation 
and chemistry. ACS Nano 8(8):7687–7703
